Viva Biotech Holdings (1873.HK)

HKD 0.89

(-2.2%)

Revenue Summary of Viva Biotech Holdings

  • Viva Biotech Holdings's latest annual revenue in 2023 was 2.15 Billion CNY , down -9.42% from previous year.
  • Viva Biotech Holdings's latest quarterly revenue in 2024 Q2 was 981.82 Million CNY , down 0.0% from previous quarter.
  • Viva Biotech Holdings reported a annual revenue of 2.37 Billion CNY in annual revenue 2022, up 13.1% from previous year.
  • Viva Biotech Holdings reported a annual revenue of 2.1 Billion CNY in annual revenue 2021, up 201.9% from previous year.
  • Viva Biotech Holdings reported a quarterly revenue of 2.15 Billion CNY for 2023 FY, down -9.42% from previous quarter.
  • Viva Biotech Holdings reported a quarterly revenue of 1.14 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Revenue of Viva Biotech Holdings (2023 - 2016)

Year Revenue Revenue Growth
2023 2.15 Billion CNY -9.42%
2022 2.37 Billion CNY 13.1%
2021 2.1 Billion CNY 201.9%
2020 696.95 Million CNY 115.74%
2019 323.05 Million CNY 53.81%
2018 210.03 Million CNY 41.68%
2017 148.24 Million CNY 53.63%
2016 96.49 Million CNY 0.0%

Peer Revenue Comparison of Viva Biotech Holdings

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD -344.708%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 59.502%